Rami Suzuki

Rami Suzuki currently serves as an External Board Director at Monex Group and Spera Pharma, Inc., and holds roles as Managing Director and Operating Partner at ARCHIMED. Additionally, Rami Suzuki is the President and Representative Director of ARC Therapies Inc. and a member of the 2024 InaRIS Fellow Selection Committee at the Inamori Foundation. In a public service capacity, Rami Suzuki contributes as a Committee Member for the Expert Research Committee for Health and Medicine Strategy at the Cabinet Office of the Government of Japan, the Strategy Committee at RIKEN, and the Life Science Committee at the Japan Ministry of Education, Culture, Sports, Science and Technology. Participation as a Board Trustee for ASrid NPO for orphan diseases also marks Rami Suzuki's commitment to health issues. Previously, Rami Suzuki was the President and Representative Director at Moderna Japan Co., Ltd. Rami Suzuki earned a Doctor of Philosophy (PhD) in Medicine from UCL.